Peptides exhibit lower affinity and a shorter half-life in the body than antibodies. Conversely,
peptides demonstrate higher efficiency in tissue penetration and cell internalization than …

Peptide-based supramolecular hydrogels have shown great promise as drug delivery
systems (DDSs) because of their excellent biocompatibility, biodegradability, biological …

Recent technological advancements in testing and monitoring instrumentation have greatly
contributed to the progress in cancer treatment by surgical, chemotherapeutic and …

Cabazitaxel, a novel tubulin inhibitor with poor affinity for P-glycoprotein, is a second-
generation taxane holding great promise for the treatment of metastatic castration-resistant …

Cancer incidence and mortality rates are increasing annually. Treatment with surgery,
chemotherapy and radiation therapy (RT) is unsatisfactory because many patients have …

The escalating rate of cancer cases, together with treatment deficiencies and long-term side
effects of currently used cancer drugs, has made this disease a global burden of the 21st …

When hydrogel materials with excellent biocompatibility and biodegradability are used as
excellent new drug carriers in the treatment of cancer, they confer the following three …

Immune checkpoint blockade (ICB) has shown remarkable therapeutic efficacy in a variety of
cancers. However, patients exhibit unexpectedly low response rates to ICB therapy owing to …

Near infrared photoimmunotherapy (NIR-PIT) is a newly developed molecular targeted
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …

Abstract Immunogenic Cell Death (ICD) is a type of cell death that kills tumor cells by
stimulating the adaptive immune response against other tumor cells. ICD depends on the …